Investigational drug · Phase 3
TILD
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Active Psoriatic Arthritis.
Phase 3Last checked: Nov 19, 2026Latest source record: Mar 10, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
1 still active
All registered trials
3
Any phase or sponsor naming "TILD"
First trial start
2020
Jul 1, 2020
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "TILD", any sponsor or status.
Conditions studied
As listed on its trial records.
- Active Psoriatic Arthritis
Approved drugs for the same conditions: Psoriatic arthritis · Immunology and inflammation
Largest trials
Live from ClinicalTrials.gov: studies naming "TILD" as an intervention, largest first.
- Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic ArthritisPivotal-lookingActive, not recruiting
Sun Pharmaceutical Industries LimitedIndustry
NCT04991116 · 529 participants · Start Jun 30, 2022 · Primary completion Dec 2028
Drug: TILD sub-cutaneous (SC) injection · For: Psoriatic Arthritis
Sites: Dothan, Alabama; Gilbert, Arizona; Mesa, Arizona · 99 sites in all
- Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)Pivotal-lookingCompleted
Sun Pharmaceutical Industries LimitedIndustry
NCT04314544 · 508 participants · Start Jul 1, 2020 · Primary completion Mar 26, 2025
Drug: TILD; matching placebo injections · For: Active Psoriatic Arthritis
Sites: Dothan, Alabama; Gilbert, Arizona; Glendale, Arizona · 97 sites in all
- Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)Pivotal-lookingActive, not recruiting
Sun Pharmaceutical Industries LimitedIndustry
NCT04314531 · 296 participants · Start Jul 1, 2020 · Primary completion Jun 4, 2025
Drug: TILD; matching placebo injections · For: Active Psoriatic Arthritis
Sites: Covina, California; Miami Beach, Florida; New Port Richey, Florida · 49 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Physiologically controlled release from an in situ forming liposomal depot.
Eugster R, Aleandri S, Bassila JB, et al. · J Control Release 2026
- Efficient Delivery of CRISPR-Cas9 RNP Complexes with Cyclodextrin-Based Nanosponges for Enhanced Genome Editing: TILD-CRISPR Integration.
Amiri S, Adibzadeh S, Khazaei Monfared Y, et al. · Int J Mol Sci 2025
- Comparative Effectiveness and Durability of Biologics Through 24 Months for Patients with Moderate-to-Severe Psoriasis: Results from the International, Observational Psoriasis Study of Health Outcomes (PSoHO).
Pinter A, Brnabic A, Trovato E, et al. · Dermatol Ther (Heidelb) 2025
- Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies.
Armstrong A, González-Cantero A, Khattri S, et al. · Dermatol Ther (Heidelb) 2024
- Characterizing the influence of various antimicrobials used for metaphylaxis against bovine respiratory disease on host transcriptome responses.
Bigelow RA, Richeson JT, McClurg M, et al. · Front Vet Sci 2023
- Investigation of the Electrical Coupling Effect for Monolithic 3-Dimensional Nonvolatile Memory Consisting of a Feedback Field-Effect Transistor Using TCAD.
Oh JH, Yu YS · Micromachines (Basel) 2023
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.